• ABOUT DRY EYE
  • Symptoms, Causes, and Diagnosis of Dry Eye
  • Treatments for Dry Eye
    • Artificial Tears
    • Prescription Options
    • Other Patient Options
• ABOUT LACRISERT^®
  • How LACRISERT^® Works
  • The Benefits of LACRISERT^®
  • Writing LACRISERT^®
  • How Patients Use LACRISERT^®
  • LACRISERT^® Efficacy Data
  • Patient Testimonials
• RESOURCES FOR YOU + YOUR PATIENTS
  • LACRISERT^® Sample Request
  • Customizable Tip Sheet
  • Aton Patient Savings Program
  • Aton PatientCARE^SM Program
  • Learn More About LACRISERT^®
  • Valuable Links
  • Presentations
• FAQs

Writing LACRISERT^®

LACRISERT^® Packaging

LACRISERT^® is a translucent, rod-shaped ophthalmic insert made up of only 5 mg of hydroxypropyl cellulose.¹

A single package of LACRISERT^® contains 60 inserts, each individually wrapped in unit-dose aluminum blister packs for sanitary purposes. The package also includes illustrated instructions, 2 flexible applicators for inserting LACRISERT^®, and a plastic storage container to store the applicators for reuse.¹

If your patient administers LACRISERT^® in each eye once daily, each package will cover 1 month of use.

LACRISERT^® Prescription

Aton Pharma is committed to ensuring that supplies of LACRISERT^® are available for your patients throughout the United States and in many countries worldwide.

Simply complete your prescription form as pictured below and have your patient drop it off at any local pharmacy.

LACRISERT^® is indicated in patients with moderate to severe Dry Eye syndromes, including keratoconjunctivitis sicca. LACRISERT^® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT^® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information
Do not use LACRISERT^® if you are allergic to hydroxypropyl cellulose. Instructions for inserting and removing LACRISERT^® should be carefully followed. If improperly placed, LACRISERT^® may result in a scratch to the cornea of your eye. Because LACRISERT^® may cause temporary blurred vision, please use caution when driving or operating machinery. Rubbing the eye(s) containing LACRISERT^® should be avoided. You should always discuss this safety information with your doctor. The following adverse reactions have been reported but were in most instances mild and temporary: temporary blurring of vision, eye discomfort or irritation, matting or stickiness of eyelashes, increased sensitivity to light, eyelid swelling, and eye redness. Talk to your doctor if you have side effects that bother you or that do not go away. You are encouraged to report side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

Reference: 1. Lacrisert [prescribing information]. Lawrenceville, NJ: Aton Pharma, Inc; 2007.